Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hyldstrup

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
The New England Journal of Medicine|September 20, 2007
Zoledronic acid and clinical fractures and mortality after hip fractureKenneth W Lyles, Cathleen S Colón-Emeric, Jay S Magaziner, et al.
Arthritis Research & Therapy|February 26, 2016
Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteoarthritis StudyLykke Midtbøll Ørnbjerg, Mikkel Østergaard, Trine Jensen, et al.
Lancet (London, England)|July 31, 2017
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trialBente L Langdahl, Cesar Libanati, Daria B Crittenden, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
The New England Journal of Medicine|September 20, 2007
Zoledronic acid and clinical fractures and mortality after hip fractureKenneth W Lyles, Cathleen S Colón-Emeric, Jay S Magaziner, et al.
Arthritis Research & Therapy|February 26, 2016
Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteoarthritis StudyLykke Midtbøll Ørnbjerg, Mikkel Østergaard, Trine Jensen, et al.
Lancet (London, England)|July 31, 2017
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trialBente L Langdahl, Cesar Libanati, Daria B Crittenden, et al.
Pageof 4